Neumafit has been finally selected for the '2025 Second Korean ARPA-H Project' promoted by the K-Health Future Initiative under the Korea Health Industry Development Institute, affiliated with the Ministry of Health and Welfare.

The project is led by Korea University College of Medicine, with Neumafit, Korea University Medical Center, CHA University, NHN, and Lonpick among the six participating joint research and development institutions. The research period is until December 2029, with a government research and development fund of up to KRW 12.75 billion (including private funding contributions, the total is KRW 15.1 billion) expected to be invested.

This research aims to develop a frailty-specialized AI multimodal foundation model, moving beyond the existing frailty diagnosis focused on cardiopulmonary function, muscle strength, and cognitive function, to evaluate and manage the quantitative level of frailty through integrated analysis including metabolic capacity. Metabolic capacity indicates 'metabolic activity' and is known as a key indicator showing the level of frailty.

The research team plans to precisely diagnose metabolic levels using respiratory data generated during light exercise and combine this with the frailty-specialized multimodal foundation model to use it as a basis for personalized exercise prescriptions for frailty prevention.

Jinmo Kim, CEO of Neumafit, stated, "By collaborating with excellent research teams to prepare for the super-aged society, we expect to expand the scope of application of respiratory metabolism analysis technology," adding, "Through this achievement, we can establish a social foundation that allows everyone to effectively manage frailty."

Popular News